FDA Shifts To More Cautious Stance On BPA
The U.S. Food and Drug Administration announced Friday that it will work to reduce infants' exposure to controversial chemical bisphenol A and support a more robust regulatory framework for the chemical,...To view the full article, register now.
Already a subscriber? Click here to view full article